Emily A. Van Vré

579 total citations
13 papers, 465 citations indexed

About

Emily A. Van Vré is a scholar working on Immunology, Immunology and Allergy and Oncology. According to data from OpenAlex, Emily A. Van Vré has authored 13 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 4 papers in Immunology and Allergy and 3 papers in Oncology. Recurrent topics in Emily A. Van Vré's work include T-cell and B-cell Immunology (6 papers), Atherosclerosis and Cardiovascular Diseases (6 papers) and Immunotherapy and Immune Responses (5 papers). Emily A. Van Vré is often cited by papers focused on T-cell and B-cell Immunology (6 papers), Atherosclerosis and Cardiovascular Diseases (6 papers) and Immunotherapy and Immune Responses (5 papers). Emily A. Van Vré collaborates with scholars based in Belgium, France and Poland. Emily A. Van Vré's co-authors include Ziad Mallat, Alain Tedgui, Hafid Ait‐Oufella, Hidde Bult, Johan Bosmans, Christiaan Vrints, Ilse Van Brussel, Guido R.Y. De Meyer, Vicky Y. Hoymans and D. Schrijvers and has published in prestigious journals such as Journal of Clinical Oncology, Arteriosclerosis Thrombosis and Vascular Biology and Journal of Immunological Methods.

In The Last Decade

Emily A. Van Vré

13 papers receiving 462 citations

Peers

Emily A. Van Vré
Delia Projahn Netherlands
K Shimizu Japan
Stephen Winikoff United States
RL Silverstein United States
Tariq Khoyratty United Kingdom
Emily A. Van Vré
Citations per year, relative to Emily A. Van Vré Emily A. Van Vré (= 1×) peers Helene Hartwig

Countries citing papers authored by Emily A. Van Vré

Since Specialization
Citations

This map shows the geographic impact of Emily A. Van Vré's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily A. Van Vré with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily A. Van Vré more than expected).

Fields of papers citing papers by Emily A. Van Vré

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily A. Van Vré. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily A. Van Vré. The network helps show where Emily A. Van Vré may publish in the future.

Co-authorship network of co-authors of Emily A. Van Vré

This figure shows the co-authorship network connecting the top 25 collaborators of Emily A. Van Vré. A scholar is included among the top collaborators of Emily A. Van Vré based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily A. Van Vré. Emily A. Van Vré is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Vré, Emily A. Van, Carolien Boeckx, M. De Bie, et al.. (2018). Optimal Evaluation of Programmed Death Ligand-1 on Tumor Cells Versus Immune Cells Requires Different Detection Methods. Archives of Pathology & Laboratory Medicine. 142(8). 982–991. 27 indexed citations
2.
Vré, Emily A. Van, et al.. (2017). Epitope mapping of PD-L1 primary antibodies (28-8, SP142, SP263, E1L3N).. Journal of Clinical Oncology. 35(15_suppl). 3028–3028. 12 indexed citations
3.
Vré, Emily A. Van, Stefanie De Schepper, Carolien Boeckx, et al.. (2016). Validated programmed cell death ligand 1 immunohistochemistry assays (E1L3N and SP142) reveal similar immune cell staining patterns in melanoma when using the same sensitive detection system. Histopathology. 70(2). 253–263. 29 indexed citations
4.
Brussel, Ilse Van, D. Schrijvers, Emily A. Van Vré, & Hidde Bult. (2013). Potential Use of Dendritic Cells for Anti-Atherosclerotic Therapy. Current Pharmaceutical Design. 19(33). 5873–5882. 8 indexed citations
5.
Ponnuswamy, Padmapriya, Emily A. Van Vré, Ziad Mallat, & Alain Tedgui. (2012). Humoral and cellular immune responses in atherosclerosis: Spotlight on B- and T-cells. Vascular Pharmacology. 56(5-6). 193–203. 25 indexed citations
6.
Vré, Emily A. Van, Hafid Ait‐Oufella, Alain Tedgui, & Ziad Mallat. (2012). Apoptotic Cell Death and Efferocytosis in Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 32(4). 887–893. 150 indexed citations
7.
Vré, Emily A. Van, Johan Bosmans, Ilse Van Brussel, et al.. (2011). Immunohistochemical characterisation of dendritic cells in human atherosclerotic lesions: possible pitfalls. Pathology. 43(3). 239–247. 27 indexed citations
8.
Vré, Emily A. Van, Ilse Van Brussel, Johan Bosmans, Christiaan Vrints, & Hidde Bult. (2011). Dendritic Cells in Human Atherosclerosis: From Circulation to Atherosclerotic Plaques. Mediators of Inflammation. 2011. 1–13. 48 indexed citations
9.
Brussel, Ilse Van, Emily A. Van Vré, Guido R.Y. De Meyer, et al.. (2011). Decreased numbers of peripheral blood dendritic cells in patients with coronary artery disease are associated with diminished plasma Flt3 ligand levels and impaired plasmacytoid dendritic cell function. Clinical Science. 120(9). 415–426. 34 indexed citations
10.
Vré, Emily A. Van, Ilse Van Brussel, Ken Op de Beeck, et al.. (2010). Changes in blood dendritic cell counts in relation to type of coronary artery disease and brachial endothelial cell function. Coronary Artery Disease. 21(2). 87–96. 27 indexed citations
11.
Brussel, Ilse Van, Emily A. Van Vré, Guido R.Y. De Meyer, et al.. (2010). Expression of dendritic cell markers CD11c/BDCA-1 and CD123/BDCA-2 in coronary artery disease upon activation in whole blood. Journal of Immunological Methods. 362(1-2). 168–175. 17 indexed citations
12.
Vré, Emily A. Van, Hidde Bult, Vicky Y. Hoymans, et al.. (2008). Human C-Reactive Protein Activates Monocyte-Derived Dendritic Cells and Induces Dendritic Cell-Mediated T-Cell Activation. Arteriosclerosis Thrombosis and Vascular Biology. 28(3). 511–518. 48 indexed citations
13.
Vré, Emily A. Van, Heleen M. van Beusekom, Christiaan Vrints, et al.. (2007). Stereology: a simplified and more time-efficient method than planimetry for the quantitative analysis of vascular structures in different models of intimal thickening. Cardiovascular Pathology. 16(1). 43–50. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026